Tamanti, Agnese
 Distribuzione geografica
Continente #
EU - Europa 1.621
NA - Nord America 1.564
AS - Asia 1.239
SA - Sud America 222
AF - Africa 74
Continente sconosciuto - Info sul continente non disponibili 59
OC - Oceania 7
Totale 4.786
Nazione #
US - Stati Uniti d'America 1.491
RU - Federazione Russa 820
SG - Singapore 518
IT - Italia 333
CN - Cina 200
BR - Brasile 169
VN - Vietnam 157
HK - Hong Kong 115
GB - Regno Unito 85
DE - Germania 81
FI - Finlandia 76
BD - Bangladesh 53
CA - Canada 47
TR - Turchia 38
FR - Francia 37
SE - Svezia 35
IE - Irlanda 33
KR - Corea 32
IN - India 30
ID - Indonesia 24
NL - Olanda 24
PL - Polonia 18
JP - Giappone 17
AR - Argentina 16
AT - Austria 16
MX - Messico 16
ZA - Sudafrica 15
ES - Italia 14
BJ - Benin 13
TG - Togo 13
IQ - Iraq 10
NG - Nigeria 9
UA - Ucraina 9
CO - Colombia 8
CL - Cile 7
PY - Paraguay 7
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
LT - Lituania 5
PH - Filippine 5
PK - Pakistan 5
AU - Australia 4
EG - Egitto 4
HR - Croazia 4
JM - Giamaica 4
KZ - Kazakistan 4
PE - Perù 4
RO - Romania 4
DZ - Algeria 3
IL - Israele 3
KE - Kenya 3
MA - Marocco 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
GY - Guiana 2
HU - Ungheria 2
JO - Giordania 2
TH - Thailandia 2
TZ - Tanzania 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BS - Bahamas 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GR - Grecia 1
IM - Isola di Man 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PG - Papua Nuova Guinea 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
Totale 4.725
Città #
Moscow 304
Ashburn 271
Singapore 257
San Jose 217
Dallas 117
Hong Kong 113
Verona 106
Council Bluffs 71
Chandler 68
Los Angeles 53
New York 52
The Dalles 48
Ho Chi Minh City 43
Helsinki 40
Beijing 39
Dublin 32
Hanoi 32
Milan 32
Munich 32
São Paulo 30
Istanbul 29
London 29
Montreal 27
Redmond 24
Santa Clara 22
Lappeenranta 21
Buffalo 19
Jakarta 18
Orem 18
Southend 17
Warsaw 17
Phoenix 16
Tokyo 15
Atlanta 14
Turku 14
Cotonou 13
Lomé 13
Princeton 13
Amsterdam 12
Chicago 12
Denver 12
Dong Ket 12
Frankfurt am Main 12
Nuremberg 12
Rome 12
Chennai 11
Johannesburg 11
Redondo Beach 11
Seattle 11
Da Nang 10
Haiphong 10
Jacksonville 9
Abuja 8
Falkenstein 8
Toronto 8
Treviso 8
Vienna 8
Bologna 7
Figino 7
Padova 7
Piscataway 7
Rio de Janeiro 7
Stockholm 7
Brooklyn 6
Charlotte 6
Chirignago 6
Jinan 6
Lawrence 6
Mexico City 6
Poplar 6
Shanghai 6
Sindelfingen 6
Tashkent 6
Ankara 5
Baghdad 5
Boston 5
Columbus 5
Duncan 5
Madrid 5
Querétaro 5
Santiago 5
Seoul 5
Turin 5
Cagliari 4
Des Moines 4
Genoa 4
Houston 4
Mumbai 4
Padua 4
Paris 4
Philadelphia 4
Redwood City 4
San Francisco 4
Sommacampagna 4
Tianjin 4
Washington 4
Barnet 3
Basel 3
Brasília 3
Brescia 3
Totale 2.709
Nome #
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 222
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 219
A combined MRI and histological evaluation of cortical pathology in multiple sclerosis 195
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 187
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 184
The use of the central vein sign in the diagnosis of multiple sclerosis: a systematic review and meta-analysis 168
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands 166
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 156
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 154
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 150
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis 147
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: a 20-year study 144
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 143
Associations between fatigue and functional connectivity of dopamine and noradrenaline circuits in Parkinson’s disease 141
Impact of model selection procedure on Deep Neural Networks ensemble for the Choroid Plexus segmentation in Multiple Sclerosis 139
Molecular-Informed Network Analysis Unveils Fatigue-Related Functional Connectivity in Parkinson's Disease 136
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? 134
ASCHOPLEX: A generalizable approach for the automatic segmentation of choroid plexus 133
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis 132
Cluster analysis showed long-term cognition can be predicted by looking at regional grey matter atrophy in the first two years of multiple sclerosis course 131
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study 131
Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis 130
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 130
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 125
Choroid plexus volume in multiple sclerosis can be estimated on structural MRI avoiding contrast injection 121
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 119
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 115
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis 113
The neural substrates of social cognition deficits in newly diagnosed multiple sclerosis patients 105
Impact of neuronal loss on relaxometry and magnetization transfer imaging estimations 102
Factors influencing longitudinal MRI structural and cognitive measures in MOGAD and MS 94
Dynamic emotion recognition and authenticity detection in multiple sclerosis: preliminary cognitive, behavioral, and neuroimaging evidence 58
Unsupervised Clustering Based on Quantitative Magnetic Resonance Imaging Features Contributes to the Characterization of MS White Matter Lesions 47
Choroid plexus volume predicts progression independent of relapse activity in early relapsing multiple sclerosis 42
Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosis 38
Quantitative Magnetic resonance imaging lesion features allow machine learning-based classification of MS patients with Progression Independent of Relapse Activity 37
The effect of cladribine tablets on intrathecal inflammation in relapsing-remitting multiple sclerosis 30
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes 21
Machine learning-based combination of the central vein sign, cortical lesions and paramagnetic rim lesions: a web-based tool for the diagnosis of multiple sclerosis 19
Paramagnetic Rim Lesions and Choroid Plexus Volume at Diagnosis Are Associated With Cognitive Progression Independent of Relapse and MRI Activity in Early Relapsing-Remitting Multiple Sclerosis 12
Quantitative MRI Uncovers Subtle Cortical Damage in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 9
Investigating the Presence of Neurodegeneration Independent of Relapses in MOGAD Compared to Relapsing-Remitting Multiple Sclerosis 4
Investigating the association between grey matter hypoperfusion and atrophy in multiple sclerosis using arterial spin labelling 3
Totale 4.786
Categoria #
all - tutte 17.690
article - articoli 14.754
book - libri 0
conference - conferenze 2.376
curatela - curatele 0
other - altro 560
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202264 0 22 0 20 0 1 5 3 1 1 2 9
2022/2023202 12 21 11 33 11 45 1 27 29 0 8 4
2023/2024216 9 12 13 23 14 32 26 15 5 17 37 13
2024/2025940 25 35 40 167 35 61 55 53 140 63 91 175
2025/20263.093 146 146 149 549 814 156 291 166 283 189 102 102
2026/2027184 74 110 0 0 0 0 0 0 0 0 0 0
Totale 4.786